LifeStance Health Group, Inc.
LFST$10.66
+$0.29 (2.80%)+2.80%
Pre-MarketLoading chart...
IndexN/A
Market Cap4.13B
Enterprise Value2.66B
Income$0.00B
Sales$0.33B
EmployeesN/A
P/E80.29
P/S1.91
P/B1.79
P/C24.70
EV/EBITDA33.80
EV/SalesN/A
EPS (ttm)0.13
EarningsN/A
Gross Margin32.37%
Oper. Margin1.70%
Profit Margin0.68%
Volume9.14M
Shs Outstand0.39B
Change2.80%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $1.25B | $1.06B | $859.54M | $667.51M | $377.22M | $212.52M |
| Cost of Revenue | $848.57M | $753.57M | $622.52M | $466.00M | $242.90M | $150.12M |
| Gross Profit | $402.40M | $302.10M | $237.02M | $201.51M | $134.32M | $62.40M |
| Gross Margin | 32.17% | 28.62% | 27.57% | 30.19% | 35.61% | 29.36% |
| Operating Expenses | $434.01M | $491.23M | $447.19M | $487.86M | $118.88M | $47.16M |
| Operating Income | $-31.61M | $-189.13M | $-210.17M | $-286.35M | $15.44M | $15.24M |
| Operating Margin | -2.53% | -17.92% | -24.45% | -42.90% | 4.09% | 7.17% |
| Net Income | $-57.44M | $-186.26M | $-215.56M | $-307.20M | $-38.07M | $5.67M |
| Net Margin | -4.59% | -17.64% | -25.08% | -46.02% | -10.09% | 2.67% |
| EPS (Basic) | $-0.15 | $-0.51 | $-0.61 | $-1.05 | $-0.83 | $0.02 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $2.12B | $2.11B | $2.17B | $1.93B | $1.57B | $280.78M |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $672.01M | $681.04M | $655.15M | $382.08M | $571.89M | $447.13M |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $1.45B | $1.43B | $1.52B | $1.55B | $997.84M | $-166.35M |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $1.45B | $1.43B | $1.52B | $1.55B | $997.84M | $-166.35M |
| Total Liabilities & Stockholders Equity | $2.12B | $2.11B | $2.17B | $1.93B | $1.57B | $280.78M |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
| Tangible Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Net Income | $-57.44M | $-186.26M | $-215.56M | $-307.20M | $-38.07M | $5.67M |
| Depreciation | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $107.26M | $-16.88M | $52.79M | $9.42M | $-8.53M | $17.05M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
Latest news
LifeStance Health Group Q2 Earnings Call Highlightsmarketbeat.com LifeStance Health Group, Inc. (LFST) Q2 2026 Earnings Call Transcriptseekingalpha.com LifeStance Health Group (LFST) Tops Q2 Earnings and Revenue Estimateszacks.com LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlookglobenewswire.com LifeStance to Host Second Quarter 2026 Earnings Conference Call on August 6, 2026globenewswire.com Are You Looking for a Top Momentum Pick? Why LifeStance Health Group (LFST) is a Great Choicezacks.com LifeStance Health (LFST) Upgraded to Strong Buy: Here's What You Should Knowzacks.com 4 Outpatient Home Health Stocks Benefiting From Industry Trendszacks.com
Show 12 more stories
Wall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Knowzacks.com Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Nowzacks.com LifeStance Health Group, Inc. (LFST) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcriptseekingalpha.com Earnings Estimates Rising for LifeStance Health (LFST): Will It Gain?zacks.com LifeStance Health Group (LFST) is a Great Momentum Stock: Should You Buy?zacks.com Wall Street Analysts See a 31.02% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?zacks.com LifeStance Health Group Q1 Earnings Call Highlightsmarketbeat.com LifeStance Health Group Announces Pricing of Secondary Public Offeringglobenewswire.com LifeStance Health Group Announces Pricing of Secondary Public Offeringglobenewswire.com Why LifeStance Health Group Zoomed 20% Higher Todayfool.com LifeStance Health Group Announces Launch of Secondary Public Offeringglobenewswire.com LifeStance Health Group, Inc. (LFST) Q1 2026 Earnings Call Transcriptseekingalpha.com
Insider Trading
View AllInsider
Type
Shares
Price
Value
Date
Company
About the company
LifeStance Health Group, Inc. specializes in delivering outpatient mental healthcare services through its subsidiary network. The company offers a comprehensive array of mental health solutions, encompassing psychiatric evaluations and treatment, specialized psychological and neuropsychological testing, and diverse therapeutic modalities including individual, family, and group therapy sessions. The organization addresses a wide spectrum of mental health conditions, ranging from common issues like anxiety and depression to more complex challenges such as bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Patients have access to care through various channels: virtually via its online platform or in-person at its many centers located throughout 32 states. LifeStance is dedicated to supporting individuals across all age groups, providing care for children, adolescents, adults, and the elderly. LifeStance Health Group, Inc. was founded in 2017 and its main offices are situated in Scottsdale, Arizona.
Discover more
You may be interested in